What does APOTHEEK KESTELYN do?

APOTHEEK KESTELYN is a pharmacy in Ieper. Public Limited, started on 28 December 1990, 2 establishments.

What is the address of APOTHEEK KESTELYN?

The registered office of APOTHEEK KESTELYN is located at Capucienenstraat 57, 8900 Ieper.

Is APOTHEEK KESTELYN still active?

Yes. According to the CBE (30 October 2026) APOTHEEK KESTELYN is active, legal situation “Normale toestand”, started on 28 December 1990.

Is APOTHEEK KESTELYN registered on Peppol?

Yes, APOTHEEK KESTELYN is registered on the Peppol network with ID 0208:0442743533.

What is the enterprise number of APOTHEEK KESTELYN?

The enterprise number of APOTHEEK KESTELYN is BE0442743533.

When was APOTHEEK KESTELYN founded?

APOTHEEK KESTELYN was founded on 28 December 1990.

Who are the directors of APOTHEEK KESTELYN?

According to the 2025 annual accounts, the directors of APOTHEEK KESTELYN are: PHARMAKES.

Is APOTHEEK KESTELYN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 December 1990; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did APOTHEEK KESTELYN make in 2025?

APOTHEEK KESTELYN posted a profit after taxes of € 206,393 in financial year 2025.

What is the revenue of APOTHEEK KESTELYN?

As a small company, APOTHEEK KESTELYN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 534,123.

How much does an employee at APOTHEEK KESTELYN earn?

The average wage cost per full-time employee at APOTHEEK KESTELYN was € 83,700 in 2025: staff costs of € 200,987 for 2.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK KESTELYN have?

According to the 2025 annual accounts, APOTHEEK KESTELYN has 2.4 full-time equivalents (FTE).

APOTHEEK KESTELYN (Public Limited) - Ieper - BE0442743533

Dossier APOTHEEK KESTELYN, printed on 30 October 2026 from databakkes.be/en/0442743533/apotheek-kestelyn. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 47 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

APOTHEEK KESTELYN from Ieper, company number BE0442743533, closed financial year 2025 with a result of € 206,393 after tax. For that financial year APOTHEEK KESTELYN recorded a gross margin of € 534,123 and equity of € 423,539. Compared with financial year 2024, the result moved from € 101,924 to € 206,393. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 31, 2025.

What it is worth Growing

€ 423,539

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 206,393

▲ 102% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 390,065

▼ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 165,000 paid out

80 % of the profit went to the shareholders, mostly to PHARMAKES (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.4

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 200,987

▲ 17% vs 2024

€ 83,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,988

▼ 16% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 299,018

▲ € 249,017 vs 2024

€ 46,112 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 85,379

▼ 82% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 37,842

▲ 24% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 695,223 Gross margin 2022: € 695,223 First fiscal year in the series	€ 480,848 Gross margin 2023: € 480,848 ▼ 31% vs 2022 (€ 695,223) Unfavourable step	€ 382,223 Gross margin 2024: € 382,223 ▼ 21% vs 2023 (€ 480,848) Unfavourable step	€ 534,123 Gross margin 2025: € 534,123 ▲ 40% vs 2024 (€ 382,223) Favourable step	▲ 40%
Profit after taxes	€ 443,281 Profit after taxes 2022: € 443,281 First fiscal year in the series	€ 205,506 Profit after taxes 2023: € 205,506 ▼ 54% vs 2022 (€ 443,281) Unfavourable step	€ 101,924 Profit after taxes 2024: € 101,924 ▼ 50% vs 2023 (€ 205,506) Unfavourable step	€ 206,393 Profit after taxes 2025: € 206,393 ▲ 102% vs 2024 (€ 101,924) Favourable step	▲ 102%
Equity	€ 354,716 Equity 2022: € 354,716 First fiscal year in the series	€ 360,223 Equity 2023: € 360,223 ▲ 2% vs 2022 (€ 354,716) Favourable step	€ 382,146 Equity 2024: € 382,146 ▲ 6% vs 2023 (€ 360,223) Favourable step	€ 423,539 Equity 2025: € 423,539 ▲ 11% vs 2024 (€ 382,146) Favourable step	▲ 11%
Total debts	€ 1,075,783 Total debts 2022: € 1,075,783 First fiscal year in the series	€ 824,007 Total debts 2023: € 824,007 ▼ 23% vs 2022 (€ 1,075,783) Favourable step	€ 1,404,397 Total debts 2024: € 1,404,397 ▲ 70% vs 2023 (€ 824,007) Unfavourable step	€ 1,456,820 Total debts 2025: € 1,456,820 ▲ 4% vs 2024 (€ 1,404,397) Unfavourable step	▲ 4%
Cash	€ 603,312 Cash 2022: € 603,312 First fiscal year in the series	€ 388,862 Cash 2023: € 388,862 ▼ 36% vs 2022 (€ 603,312) Unfavourable step	€ 412,993 Cash 2024: € 412,993 ▲ 6% vs 2023 (€ 388,862) Favourable step	€ 390,065 Cash 2025: € 390,065 ▼ 6% vs 2024 (€ 412,993) Unfavourable step	▼ 6%
Land & buildings	€ 112,660 Land & buildings 2022: € 112,660 First fiscal year in the series	€ 96,076 Land & buildings 2023: € 96,076 ▼ 15% vs 2022 (€ 112,660) Unchanged	€ 75,000 Land & buildings 2024: € 75,000 ▼ 22% vs 2023 (€ 96,076) Unchanged	€ 519,616 Land & buildings 2025: € 519,616 ▲ € 444,616 vs 2024 (€ 75,000) Unchanged	▲ € 444,616
Retained profit	€ 292,716 Retained profit 2022: € 292,716 First fiscal year in the series	€ 298,223 Retained profit 2023: € 298,223 ▲ 2% vs 2022 (€ 292,716) Favourable step	€ 320,146 Retained profit 2024: € 320,146 ▲ 7% vs 2023 (€ 298,223) Favourable step	€ 361,539 Retained profit 2025: € 361,539 ▲ 13% vs 2024 (€ 320,146) Favourable step	▲ 13%
Dividend	€ 443,000 Dividend 2022: € 443,000 First fiscal year in the series	€ 200,000 Dividend 2023: € 200,000 ▼ 55% vs 2022 (€ 443,000) Unchanged	€ 80,000 Dividend 2024: € 80,000 ▼ 60% vs 2023 (€ 200,000) Unchanged	€ 165,000 Dividend 2025: € 165,000 ▲ 106% vs 2024 (€ 80,000) Unchanged	▲ 106%
Bank debt	€ 130,000 Bank debt 2022: € 130,000 First fiscal year in the series	€ 90,000 Bank debt 2023: € 90,000 ▼ 31% vs 2022 (€ 130,000) Favourable step	€ 50,000 Bank debt 2024: € 50,000 ▼ 44% vs 2023 (€ 90,000) Favourable step	€ 299,018 Bank debt 2025: € 299,018 ▲ € 249,017 vs 2024 (€ 50,000) Unfavourable step	▲ € 249,017
Balance sheet total	€ 1,430,499 Balance sheet total 2022: € 1,430,499 First fiscal year in the series	€ 1,184,229 Balance sheet total 2023: € 1,184,229 ▼ 17% vs 2022 (€ 1,430,499) Unchanged	€ 1,786,544 Balance sheet total 2024: € 1,786,544 ▲ 51% vs 2023 (€ 1,184,229) Unchanged	€ 1,880,359 Balance sheet total 2025: € 1,880,359 ▲ 5% vs 2024 (€ 1,786,544) Unchanged	▲ 5%
Employees (FTE)	2.7 Employees (FTE) 2022: 2.7 First fiscal year in the series	2.5 Employees (FTE) 2023: 2.5 ▼ 0.2 vs 2022 (2.7) Unchanged	2.5 Employees (FTE) 2024: 2.5 Unchanged (2.5) Unchanged	2.4 Employees (FTE) 2025: 2.4 ▼ 0.1 vs 2024 (2.5) Unchanged	▼ 0.1

Key figures of APOTHEEK KESTELYN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.

What happened to APOTHEEK KESTELYN?

What happened at APOTHEEK KESTELYN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 31, 2025 New annual accounts for financial year 2025: profit of € 206,393 (▲ 102% vs 2024). Source: NBB ↗
2018 PHARMAKES became a director. NBB
Jun 1, 2015 New establishment in Ieper. KBO
Jun 19, 1991 New establishment in Ieper. KBO
Dec 28, 1990 Start of the company according to the CBE. KBO

In short

From € 443,281 profit in 2022 to € 206,393 profit in 2025.

Paid € 3,221 in corporate taxes since 2022.

Best year ever: 2022, with € 443,281 profit.

On average € 222,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

PHARMAKES 99.9%

The stake of PHARMAKES comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK KESTELYN

Behind APOTHEEK KESTELYN is PHARMAKES. The shares are held by PHARMAKES (99.9%).

Directors

According to the 2025 annual accounts

PHARMAKES

Director · represented by Kestelyn ROEL

Also active at: IMMOKES

since 2018

Shareholders

PHARMAKES

99.9%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Capucienenstraat 57

8900 Ieper

2.242.341.773

Haiglaan 166

8900 Ieper

Active since 1 June 2015

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

KESTELYN

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0442.743.533

VAT number

BE 0442.743.533

Registered office

Capucienenstraat 57, 8900 Ieper

Names & denominations

APOTHEEK KESTELYN

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

28 December 1990

Peppol

Active · Active since 19 Mar 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK KESTELYN

Warning lights

Financials

What happened to APOTHEEK KESTELYN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions